Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-24 @ 2:56 PM
NCT ID:
NCT02621359
Eligibility Criteria:
Inclusion Criteria:
* Patients with helicobacter infection.
* in whom the standard triple therapy (clarithromycin-based triple therapy) failed
Exclusion Criteria:
* Patients under 18 or over 65 years of age.
* Those with co-existing serious illnesses such as liver cirrhosis, uremia and gastrointestinal malignancies
* pregnancy/lactation
* having contraindication or allergy to any of the study drugs
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02621359
Study Brief:
Protocol Section:
NCT02621359